Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Total Liabilities (2018 - 2026)

Viemed Healthcare filings provide 8 years of Total Liabilities readings, the most recent being $55.6 million for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 27.11% to $55.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $55.6 million, a 27.11% increase, with the full-year FY2025 number at $55.6 million, up 27.11% from a year prior.
  • Total Liabilities hit $55.6 million in Q4 2025 for Viemed Healthcare, down from $66.9 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $66.9 million in Q3 2025 to a low of $19.9 million in Q4 2022.
  • Median Total Liabilities over the past 5 years was $39.6 million (2023), compared with a mean of $36.0 million.
  • Biggest five-year swings in Total Liabilities: tumbled 39.71% in 2021 and later soared 105.52% in 2023.
  • Viemed Healthcare's Total Liabilities stood at $23.1 million in 2021, then fell by 13.8% to $19.9 million in 2022, then surged by 105.52% to $41.0 million in 2023, then grew by 6.75% to $43.8 million in 2024, then rose by 27.11% to $55.6 million in 2025.
  • The last three reported values for Total Liabilities were $55.6 million (Q4 2025), $66.9 million (Q3 2025), and $43.0 million (Q2 2025) per Business Quant data.